Johns Hopkins Cancer Center | Strategic Alliance Partners

Latest from Johns Hopkins Cancer Center

Dr. Spivak on Diagnosing Essential Thrombocythemia

December 09, 2020

Video

Jerry Le Pow Spivak, MD, discusses diagnosing essential thrombocythemia.

Future Efforts Focused on Optimizing TKI Use Across the Continuum of Care for EGFR+ NSCLC

November 19, 2020

Article

Kristen A. Marrone, MD, discusses research efforts with osimertinib in EGFR-mutated lung cancer, overcoming resistance to the agent, and optimizing sequential molecular testing.

CRC Treatment Enters New Era Where Personalized Care Is King

November 16, 2020

Article

Nilofer S. Azad, MD, highlights colorectal cancer treatment and how it has entered an era that is both exciting and challenging.

Dr. Azad on Selecting Between Regorafenib and TAS-102 in CRC

October 30, 2020

Video

Nilofer Saba Azad, MD, discusses selecting between regorafenib and TAS-102 in colorectal cancer.

Dr. Azad on Third-Line Treatment Options in CRC

October 29, 2020

Video

Nilofer Saba Azad, MD, discusses third-line treatment options for patients with colorectal cancer.

Dr. Levy on the Mechanism of Action of Telaglenastat in NSCLC

October 28, 2020

Video

Benjamin P. Levy, MD, discusses the mechanism of action of telaglenastat in non–small cell lung cancer.